CalibrateBrooklyn, New York, United States
Disclosure information not submitted.
SAT-719 - Mitigating Sarcopenic Risk in GLP-1 Pharmacotherapy: Impact of a Multi-Pillar Digital Metabolic Reset Program on Muscle Mass Preservation
Saturday, June 13, 20269:30 AM - 4:30 PM CT